Histopathological evaluation of hyperthermo-chemo-radiotherapy for carcinoma of the esophagus

J Surg Oncol. 1986 Jun;32(2):82-5. doi: 10.1002/jso.2930320206.

Abstract

The effectiveness of preoperative hyperthermo-chemo-radiotherapy for 25 patients with carcinoma of the esophagus was histopathologically compared with findings in 104 patients treated preoperatively with irradiation only. The preoperative hyperthermo-chemo-radiotherapy increased the rate of "markedly effective" in the resected tissue, when compared with findings in cases of irradiation only. With regard to long survival rates, the 5-year survival rates of patients classed as "markedly effective" with preoperative combined therapy exceeded events in patients classed as "moderately effective," and "ineffective," with statistical significance. Preoperative hyperthermo-chemo-radiotherapy is the recommended treatment for patients with carcinoma of the esophagus.

MeSH terms

  • Aged
  • Cobalt Radioisotopes / therapeutic use
  • Combined Modality Therapy
  • Esophageal Neoplasms / pathology*
  • Esophageal Neoplasms / surgery
  • Esophageal Neoplasms / therapy
  • Female
  • Humans
  • Hyperthermia, Induced*
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Postoperative Complications / etiology
  • Preoperative Care*
  • Radioisotope Teletherapy
  • Radiotherapy Dosage

Substances

  • Cobalt Radioisotopes